HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-inflammatory effects of Tat-Annexin protein on ovalbumin-induced airway inflammation in a mouse model of asthma.

Abstract
Chronic airway inflammation is a key feature of bronchial asthma. Annexin-1 (ANX1) is an anti-inflammatory protein that is an important modulator and plays a key role in inflammation. Although the precise action of ANX1 remains unclear, it has emerged as a potential drug target for inflammatory diseases such as asthma. To examine the protective effects of ANX1 protein on ovalbumin (OVA)-induced asthma in animal models, we used a cell-permeable Tat-ANX1 protein. Mice sensitized and challenged with OVA antigen had an increased amount of cytokines and eosinophils in their bronchoalveolar lavage (BAL) fluid. However, administration of Tat-ANX1 protein before OVA challenge significantly decreased the levels of cytokines (interleukin (IL)-4, IL-5, and IL-13) and BAL fluid in lung tissues. Furthermore, OVA significantly increased the activation of mitogen-activated protein kinase (MAPK) in lung tissues, whereas Tat-ANX1 protein markedly reduced phosphorylation of MAPKs such as extracellular signal-regulated protein kinase, p38, and stress-activated protein kinase/c-Jun N-terminal kinase. These results suggest that transduced Tat-ANX1 protein may be a potential protein therapeutic agent for the treatment of lung disorders including asthma.
AuthorsSun Hwa Lee, Dae Won Kim, Hye Ri Kim, Su Jung Woo, So Mi Kim, Hyo Sang Jo, Seong Gyu Jeon, Sung-Woo Cho, Jong Hoon Park, Moo Ho Won, Jinseu Park, Won Sik Eum, Soo Young Choi
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 417 Issue 3 Pg. 1024-9 (Jan 20 2012) ISSN: 1090-2104 [Electronic] United States
PMID22222376 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Annexin A1
  • Annexins
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines
  • Gene Products, tat
  • Recombinant Fusion Proteins
  • Tat-ANX1 fusion protein
  • Ovalbumin
Topics
  • Animals
  • Annexin A1 (administration & dosage, therapeutic use)
  • Annexins (administration & dosage, therapeutic use)
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use)
  • Asthma (drug therapy, prevention & control)
  • Cytokines (antagonists & inhibitors, biosynthesis)
  • Disease Models, Animal
  • Female
  • Gene Products, tat (administration & dosage, therapeutic use)
  • Mice
  • Mice, Inbred BALB C
  • Ovalbumin
  • Recombinant Fusion Proteins (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: